Decrease in TSH Receptor Autoantibodies during Antithyroid Treatment: Relationship with a Long Noncoding Heg RNA and Cdk1 mRNA in Mononuclear Cells

Table 1

Cdk1 mRNA concentrations expressed in zmol/μg DNA (median and 25% and 75% ranges) in untreated and treated patients with Graves’ disease and in controls.

Untreated patients	Treated patients	Normal subjects
33 (22 to 39)	13 (10–17)*	27 (18–34)

*Significantly different from the two other groups (𝑃<0.001).